XML 26 R16.htm IDEA: XBRL DOCUMENT
v3.25.4

Accrued Expenses and Other Current Liabilities | 12 Months Ended
--- | ---
Dec. 31, 2025
Payables and Accruals [Abstract] |
Accrued Expenses and Other Current Liabilities | 5. Accrued Expenses and Other Current Liabilities Accrued expenses and other current liabilities consisted of the following:
|  | December 31, |
|  | 2025 |  |  | 2024 |
Clinical and development costs |  | $ | 246 |  |  | $ | 422 |
Manufacturing and quality costs |  |  | 145 |  |  |  | 478 |
Payroll and employee-related costs |  |  | 2,685 |  |  |  | 7,656 |
Facility and other |  |  | 896 |  |  |  | 2,163 |
|  | $ | 3,972 |  |  | $ | 10,719 |

X
- Definition The entire disclosure for accounts payable, accrued expenses, and other liabilities that are classified as current at the end of the reporting period. + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Topic 720 -SubTopic 30 -Name Accounting Standards Codification -Section 45 -Paragraph 1 -Publisher FASB -URI https://asc.fasb.org/1943274/2147483384/720-30-45-1 + Details
Name: | us-gaap_AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureCurrentTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- References No definition available. + Details
Name: | us-gaap_PayablesAndAccrualsAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration